CoChat

The Role of Presenilins in γ-Secretase Activity

Open access
Wolfe, Michael S., Haass, Christian · 2001 · Journal of Biological Chemistry
Cited by 132

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

Abstract

Alzheimer's disease amyloid-β peptide amyloid-β precursor protein familial AD presenilin transmembrane domain tumor necrosis factor-α converting enzyme Notch intracellular domain endoplasmic reticulum It is an aphorism that basic biological research lays the groundwork for solving important biomedical problems. However, the reverse is true as well: focusing on problems of human disease can lead to important new insights into the intricacies of nature. Research on Alzheimer's disease (AD)1provides a case study for the latter, where the race to identify molecular players involved in pathogenesis has unveiled some unexpected and fascinating aspects of protease biochemistry and proteolysis-dependent signal transduction. The 40–42-residue amyloid-β peptide (Aβ) is implicated in the early pathogenic events that lead to AD, and this peptide is carved out of the amyloid-β precursor protein (APP) by β- and γ-secretases (Fig. 1 A) (1Selkoe D.J. Nature. 1999; 399: A23-31Crossref PubMed Scopus (1520) Google Scholar). These two proteases are considered such important drug targets that the search for inhibitors of Aβ production within pharmaceutical companies has gone on for years even though both β- and γ-secretases remained unknown until very recently. Last year, β-secretase was identified as a new membrane-tethered member of the aspartyl protease family (2Vassar R. Bennett B.D. Babu-Khan S. Kahn S. Mendiaz E.A. Denis P. Teplow D.B. Ross S. Amarante P. Loeloff R. et al.Science. 1999; 286: 735-741Crossref PubMed Scopus (3271) Google Scholar, 3Sinha S. Anderson J.P. Barbour R. Basi G.S. Caccavello R. Davis D. Doan M. Dovey H.F. Frigon N. Hong J. et al.Nature. 1999; 402: 537-540Crossref PubMed Scopus (1474) Google Scholar, 4Yan R. Bienkowski M.J. Shuck M.E. Miao H. Tory M.C. Pauley A.M. Brashier J.R. Stratman N.C. Mathews W.R. Buhl A.E. et al.Nature. 1999; 402: 533-537Crossref PubMed Scopus (1329) Google Scholar, 5Hussain I. Powell D. Howlett D.R. Tew D.G. Meek T.D. Chapman C. Gloger I.S. Murphy K.E. Southa C.D. Ryan D.M. et al.Mol. Cell. Neurosci. 1999; 14: 419-427Crossref PubMed Scopus (997) Google Scholar, 6Lin X. Koelsch G. Wu S. Downs D. Dashti A. Tang J. Proc. Natl. Acad. Sci. U. S. A. 2000; 97: 1456-1460Crossref PubMed Scopus (738) Google Scholar), a finding that should greatly facilitate drug discovery. α-Secretases, which prevent Aβ formation by cleaving in the middle of the amyloid domain (7Esch F.S. Keim P.S. Beattie E.C. Blacher R.W. Culwell A.R. Oltersdorf T. McClure D. Ward P.J. Science. 1990; 248: 1122-1124Crossref PubMed Scopus (1202) Google Scholar), have now been shown to be members of the ADAM family (adisintegrin andmetalloprotease) (8Lammich S. Kojro E. Postina R. Gilbert S. Pfeiffer R. Jasionowski M. Haass C. Fahrenholz F. Proc. Natl. Acad. Sci. U. S. A. 1999; 96: 3922-3927Crossref PubMed Scopus (977) Google Scholar, 9Buxbaum J.D. Liu K.N. Luo Y. Slack J.L. Stocking K.L. Peschon J.J. Johnson R.S. Castner B.J. Cerretti D.P. Black R.A. J. Biol. Chem. 1998; 273: 27765-27767Abstract Full Text Full Text PDF PubMed Scopus (834) Google Scholar). At the same time, the mysterious γ-secretase is giving up its secrets as well. Genetic studies of families susceptible to autosomal dominant, early onset (<60 years) AD underscore the importance of Aβ formation to the disease process (10Hardy J. Trends Neurosci. 1997; 20: 154-159Abstract Full Text Full Text PDF PubMed Scopus (1267) Google Scholar, 11Selkoe D.J. Science. 1997; 275: 630-631Crossref PubMed Scopus (844) Google Scholar). Several different missense mutations in the APP gene on chromosome 21 cause familial AD (FAD), and these mutations are found immediately near the α-, β-, or γ-secretase processing sites. A Lys → Asn/Met → Leu double mutation near the β-secretase cleavage site found in a Swedish pedigree leads to increased Aβ production (both Aβ40 and Aβ42) (12Citron M. Oltersdorf T. Haass C. McConlogue L. Hung A.Y. Seubert P. Vigo-Pelfrey C. Lieberburg I. Selkoe D.J. Nature. 1992; 360: 672-674Crossref PubMed Scopus (1527) Google Scholar), and indeed purified β-secretase cuts peptide substrates with the “Swedish mutation” better than peptides based on the wild-type sequence (2Vassar R. Bennett B.D. Babu-Khan S. Kahn S. Mendiaz E.A. Denis P. Teplow D.B. Ross S. Amarante P. Loeloff R. et al.Science. 1999; 286: 735-741Crossref PubMed Scopus (3271) Google Scholar, 4Yan R. Bienkowski M.J. Shuck M.E. Miao H. Tory M.C. Pauley A.M. Brashier J.R. Stratman N.C. Mathews W.R. Buhl A.E. et al.Nature. 1999; 402: 533-537Crossref PubMed Scopus (1329) Google Scholar, 6Lin X. Koelsch G. Wu S. Downs D. Dashti A. Tang J. Proc. Natl. Acad. Sci. U. S. A. 2000; 97: 1456-1460Crossref PubMed Scopus (738) Google Scholar). The several FAD-causing mutations in APP near the γ-secretase processing site also affect Aβ production, but in these cases the mutations alter the specificity of the protease, leading to increases in the 42-residue Aβ variant (13Suzuki N. Cheung T.T. Cai X.D. Od

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1074/jbc.r000026200

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 17 references

Cited by

See all 132

Metadata

Authors
Wolfe, M. S., & Haass, C.
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
2001-02
Volume
276
Issue
8
Pages
5413-5416
ISSN
0021-9258 (ISSN-L)
OpenAlex
W1574188788
Cited by
132
References
17
FWCI
11.79
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Role of Presenilins in γ-Secretase Activity. https://app.cochat.ai/papers/10.1074/jbc.r000026200
The paper
Wolfe, M. S., & Haass, C. (2001). The Role of Presenilins in γ-Secretase Activity. Journal of Biological Chemistry. https://doi.org/10.1074/jbc.r000026200

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.